NASDAQ : DMII

Drugs Made In America Acquisition II Corp. — Company profile

Financials · Shell Companies · United States

Last price 10.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 649.74M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Details

NameDrugs Made In America Acquisition II Corp.
SectorFinancials
IndustryShell Companies
Founded2024
Ipo Date2025-09-25
CeoRoger Bendelac
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price10.00
IsinKYG2851K1040
CusipG2851K104
Cik2040475
Sic6770

Key executives

NameTitle
Roger BendelacChief Executive Officer

Contact

Address420 Lexington Avenue, Suite 1402, New York, New York 10170, United States
Phone917 982 4565